vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and TWIN DISC INC (TWIN). Click either name above to swap in a different company.
Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $90.2M, roughly 1.9× TWIN DISC INC). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 0.3%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs 10.3%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Twin Disc, Inc. designs, manufactures, and distributes power transmission equipment for a wide range of applications, including marine, off-road vehicle, and industrial. The company was founded in 1918 to manufacture clutches for farm tractors. It is now a worldwide company with subsidiaries or sales offices in Asia, Europe, North America, Oceania, and South America.
ESPR vs TWIN — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $90.2M |
| Net Profit | — | $22.4M |
| Gross Margin | — | 24.8% |
| Operating Margin | 50.6% | 2.3% |
| Net Margin | — | 24.8% |
| Revenue YoY | 143.7% | 0.3% |
| Net Profit YoY | — | 2334.3% |
| EPS (diluted) | $0.32 | $1.55 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $90.2M | ||
| Q3 25 | $87.3M | $80.0M | ||
| Q2 25 | $82.4M | $96.7M | ||
| Q1 25 | $65.0M | $81.2M | ||
| Q4 24 | $69.1M | $89.9M | ||
| Q3 24 | $51.6M | $72.9M | ||
| Q2 24 | $73.8M | $84.4M | ||
| Q1 24 | $137.7M | $74.2M |
| Q4 25 | — | $22.4M | ||
| Q3 25 | $-31.3M | $-518.0K | ||
| Q2 25 | $-12.7M | $1.4M | ||
| Q1 25 | $-40.5M | $-1.5M | ||
| Q4 24 | — | $919.0K | ||
| Q3 24 | $-29.5M | $-2.8M | ||
| Q2 24 | $-61.9M | $7.4M | ||
| Q1 24 | $61.0M | $3.8M |
| Q4 25 | — | 24.8% | ||
| Q3 25 | — | 28.7% | ||
| Q2 25 | — | 31.0% | ||
| Q1 25 | — | 26.7% | ||
| Q4 24 | — | 24.1% | ||
| Q3 24 | — | 26.5% | ||
| Q2 24 | — | 29.7% | ||
| Q1 24 | — | 28.2% |
| Q4 25 | 50.6% | 2.3% | ||
| Q3 25 | -11.4% | 2.8% | ||
| Q2 25 | 8.6% | 5.5% | ||
| Q1 25 | -34.0% | 2.4% | ||
| Q4 24 | -6.4% | 3.1% | ||
| Q3 24 | -31.0% | -0.2% | ||
| Q2 24 | 3.5% | 5.6% | ||
| Q1 24 | 52.5% | 4.9% |
| Q4 25 | — | 24.8% | ||
| Q3 25 | -35.9% | -0.6% | ||
| Q2 25 | -15.4% | 1.5% | ||
| Q1 25 | -62.2% | -1.8% | ||
| Q4 24 | — | 1.0% | ||
| Q3 24 | -57.2% | -3.8% | ||
| Q2 24 | -83.9% | 8.8% | ||
| Q1 24 | 44.3% | 5.2% |
| Q4 25 | $0.32 | $1.55 | ||
| Q3 25 | $-0.16 | $-0.04 | ||
| Q2 25 | $-0.06 | $0.10 | ||
| Q1 25 | $-0.21 | $-0.11 | ||
| Q4 24 | $-0.14 | $0.07 | ||
| Q3 24 | $-0.15 | $-0.20 | ||
| Q2 24 | $-0.33 | $0.54 | ||
| Q1 24 | $0.34 | $0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | — |
| Total DebtLower is stronger | — | $44.5M |
| Stockholders' EquityBook value | $-302.0M | $184.5M |
| Total Assets | $465.9M | $384.0M |
| Debt / EquityLower = less leverage | — | 0.24× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | — | ||
| Q3 25 | $92.4M | — | ||
| Q2 25 | $86.1M | — | ||
| Q1 25 | $114.6M | — | ||
| Q4 24 | $144.8M | — | ||
| Q3 24 | $144.7M | — | ||
| Q2 24 | $189.3M | — | ||
| Q1 24 | $226.6M | — |
| Q4 25 | — | $44.5M | ||
| Q3 25 | — | $43.7M | ||
| Q2 25 | — | $31.4M | ||
| Q1 25 | — | $40.8M | ||
| Q4 24 | — | $24.9M | ||
| Q3 24 | — | $29.8M | ||
| Q2 24 | — | $25.8M | ||
| Q1 24 | — | $17.0M |
| Q4 25 | $-302.0M | $184.5M | ||
| Q3 25 | $-451.4M | $160.3M | ||
| Q2 25 | $-433.5M | $164.0M | ||
| Q1 25 | $-426.2M | $149.5M | ||
| Q4 24 | $-388.7M | $147.0M | ||
| Q3 24 | $-370.2M | $157.5M | ||
| Q2 24 | $-344.2M | $154.7M | ||
| Q1 24 | $-294.3M | $146.3M |
| Q4 25 | $465.9M | $384.0M | ||
| Q3 25 | $364.0M | $363.5M | ||
| Q2 25 | $347.1M | $355.6M | ||
| Q1 25 | $324.0M | $332.9M | ||
| Q4 24 | $343.8M | $307.4M | ||
| Q3 24 | $314.1M | $323.5M | ||
| Q2 24 | $352.3M | $312.1M | ||
| Q1 24 | $373.1M | $288.8M |
| Q4 25 | — | 0.24× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | — | 0.27× | ||
| Q4 24 | — | 0.17× | ||
| Q3 24 | — | 0.19× | ||
| Q2 24 | — | 0.17× | ||
| Q1 24 | — | 0.12× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $4.6M |
| Free Cash FlowOCF − Capex | — | $1.2M |
| FCF MarginFCF / Revenue | — | 1.4% |
| Capex IntensityCapex / Revenue | 0.0% | 3.7% |
| Cash ConversionOCF / Net Profit | — | 0.20× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-70.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $4.6M | ||
| Q3 25 | $-4.3M | $-7.5M | ||
| Q2 25 | $-31.4M | $16.4M | ||
| Q1 25 | $-22.6M | $3.2M | ||
| Q4 24 | $-35.0M | $8.7M | ||
| Q3 24 | $-35.3M | $-4.3M | ||
| Q2 24 | $-7.2M | $11.4M | ||
| Q1 24 | $53.8M | $6.2M |
| Q4 25 | — | $1.2M | ||
| Q3 25 | — | $-11.0M | ||
| Q2 25 | — | $8.7M | ||
| Q1 25 | — | $906.0K | ||
| Q4 24 | — | $5.9M | ||
| Q3 24 | $-35.5M | $-6.7M | ||
| Q2 24 | $-7.3M | $10.3M | ||
| Q1 24 | $53.8M | $4.0M |
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | -13.7% | ||
| Q2 25 | — | 9.0% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | — | 6.5% | ||
| Q3 24 | -68.7% | -9.2% | ||
| Q2 24 | -9.9% | 12.2% | ||
| Q1 24 | 39.0% | 5.5% |
| Q4 25 | 0.0% | 3.7% | ||
| Q3 25 | 0.0% | 4.3% | ||
| Q2 25 | 0.0% | 8.0% | ||
| Q1 25 | 0.0% | 2.8% | ||
| Q4 24 | 0.0% | 3.1% | ||
| Q3 24 | 0.3% | 3.2% | ||
| Q2 24 | 0.1% | 1.3% | ||
| Q1 24 | 0.1% | 2.9% |
| Q4 25 | — | 0.20× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 11.55× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 9.42× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 1.54× | ||
| Q1 24 | 0.88× | 1.63× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
TWIN
Segment breakdown not available.
